These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20207106)

  • 1. Tardive dyskinesia and intellectual disability: an examination of demographics and topography in adults with dual diagnosis and atypical antipsychotic use.
    Fodstad JC; Bamburg JW; Matson JL; Mahan S; Hess JA; Neal D; Holloway J
    Res Dev Disabil; 2010; 31(3):750-9. PubMed ID: 20207106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The convergent and divergent validity of the Matson Evaluation of Drug Side-effects (MEDS) and the Dyskinesia Identification System: Condensed User Scale (DISCUS).
    Matson JL; Fodstad JC; Rivet TT
    J Intellect Dev Disabil; 2008 Dec; 33(4):337-44. PubMed ID: 19039694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focus on lower risk of tardive dyskinesia with atypical antipsychotics.
    Nasrallah HA
    Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for tardive dyskinesia in adults with intellectual disability, comorbid psychopathology, and long-term psychotropic use.
    Matson JL; Fodstad JC; Neal D; Dempsey T; Rivet TT
    Res Dev Disabil; 2010; 31(1):108-16. PubMed ID: 19720497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM
    J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyskinetic movement disorder among adults with mental retardation: phenomenology and co-occurrence with stereotypy.
    Bodfish JW; Newell KM; Sprague RL; Harper VN; Lewis MH
    Am J Ment Retard; 1996 Sep; 101(2):118-29. PubMed ID: 8883667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
    Akbostanci MC; Atbaşoğlu EC; Balaban H
    Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic drug side effects for persons with intellectual disability.
    Matson JL; Mahan S
    Res Dev Disabil; 2010; 31(6):1570-6. PubMed ID: 20580203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia in patients receiving lithium maintenance therapy.
    Perényi A; Szücs R; Frecska E
    Biol Psychiatry; 1984 Nov; 19(11):1573-8. PubMed ID: 6151403
    [No Abstract]   [Full Text] [Related]  

  • 11. Antipsychotic medications and drug-induced movement disorders other than parkinsonism: a population-based cohort study in older adults.
    Lee PE; Sykora K; Gill SS; Mamdani M; Marras C; Anderson G; Shulman KI; Stukel T; Normand SL; Rochon PA
    J Am Geriatr Soc; 2005 Aug; 53(8):1374-9. PubMed ID: 16078964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia: managing a common neuroleptic side effect.
    Jeste DV; Krull AJ; Kilbourn K
    Geriatrics; 1990 Dec; 45(12):49-54. PubMed ID: 1979304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Examination of Psychotropic Medication Side Effects: does taking a greater number of psychotropic medications from different classes affect presentation of side effects in adults with ID?
    Mahan S; Holloway J; Bamburg JW; Hess JA; Fodstad JC; Matson JL
    Res Dev Disabil; 2010; 31(6):1561-9. PubMed ID: 20542660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychoactive drug use in an institution for intellectually handicapped persons.
    Sachdev PS
    Med J Aust; 1991 Jul; 155(2):75-9. PubMed ID: 1677447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study. UK700 Group.
    van Os J; Walsh E; van Horn E; Tattan T; Bale R; Thompson SG
    Acta Psychiatr Scand; 2000 Apr; 101(4):300-6. PubMed ID: 10782550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors related to the severity of tardive dyskinesia.
    Wade JB; Hart RP; Dougherty LM
    Brain Cogn; 1993 Sep; 23(1):71-80. PubMed ID: 8105823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
    Wolf ME; DeWolfe AS; Mosnaim AD
    Hillside J Clin Psychiatry; 1987; 9(1):3-11. PubMed ID: 2888712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.